dx 9065a has been researched along with isoxazoles in 1 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (isoxazoles) | Trials (isoxazoles) | Recent Studies (post-2010) (isoxazoles) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 8,633 | 900 | 3,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crain, EJ; Knabb, RM; Quan, ML; Watson, CA; Wexler, RR; Wong, PC | 1 |
1 other study(ies) available for dx 9065a and isoxazoles
| Article | Year |
|---|---|
Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.
Topics: Animals; Anticoagulants; Arteriovenous Shunt, Surgical; Blood Coagulation; Dalteparin; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Humans; In Vitro Techniques; Isoxazoles; Male; Naphthalenes; Platelet Aggregation; Propionates; Rabbits; Recombinant Proteins; Sulfonamides; Tetrazoles; Thrombosis | 2000 |